Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001682638-26-000002·FAIRBAIRN EMILY
Schedule 13D ownership disclosure
IN8bio, Inc.
Common Stock, $0.0001 par value per share · CUSIP: 45674E208
Event date: 2025-12-22
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- EMILY FAIRBAIRNReported CIK 0001682638
Shares: 733,293.00 · Class: 7.5%
- Malcom Fairbairn
Shares: 727,681.00 · Class: 7.5%
- Malcom and Emily Fairbairn 2010 CRUT
Shares: 724,637.00 · Class: 7.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001682638-26-000002
- Form type
- SCHEDULE 13D
- Filer
- FAIRBAIRN EMILY
- CIK
- CIK 1682638
- Filed
- Jan 02, 2026
- Reporting period
- Dec 22, 2025
- Description
- Schedule 13D beneficial ownership